Wong F - Search Results

1

Variations in albumin use in patients with cirrhosis: An AASLD members survey.

Bajaj JS, O'Leary JG, Wong F, Kamath PS. Bajaj JS, et al. Among authors: wong f. Hepatology. 2015 Dec;62(6):1923-4. doi: 10.1002/hep.27789. Epub 2015 Apr 8. Hepatology. 2015. PMID: 25783561 No abstract available.

2

The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis.

Wong F, Liu P, Blendis L. Wong F, et al. Hepatology. 2002 Jun;35(6):1449-58. doi: 10.1053/jhep.2002.33637. Hepatology. 2002. PMID: 12029630 Clinical Trial.

3

The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.

Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V. Moore KP, et al. Among authors: wong f. Hepatology. 2003 Jul;38(1):258-66. doi: 10.1053/jhep.2003.50315. Hepatology. 2003. PMID: 12830009 Review.

4

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.

Wong F, Pantea L, Sniderman K. Wong F, et al. Hepatology. 2004 Jul;40(1):55-64. doi: 10.1002/hep.20262. Hepatology. 2004. PMID: 15239086 Clinical Trial.

5

The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.

Therapondos G, Hol L, Benjaminov F, Wong F. Therapondos G, et al. Among authors: wong f. Hepatology. 2006 Sep;44(3):640-9. doi: 10.1002/hep.21309. Hepatology. 2006. PMID: 16941706

6

Hyponatremia in cirrhosis: Results of a patient population survey.

Angeli P, Wong F, Watson H, Ginès P; CAPPS Investigators. Angeli P, et al. Among authors: wong f. Hepatology. 2006 Dec;44(6):1535-42. doi: 10.1002/hep.21412. Hepatology. 2006. PMID: 17133458

7

Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome.

Wong F, Moore K, Dingemanse J, Jalan R. Wong F, et al. Hepatology. 2008 Jan;47(1):160-8. doi: 10.1002/hep.21940. Hepatology. 2008. PMID: 17886336 Clinical Trial.

8

Bacterial infections in end-stage liver disease: current challenges and future directions.

Bajaj JS, O'Leary JG, Wong F, Reddy KR, Kamath PS. Bajaj JS, et al. Among authors: wong f. Gut. 2012 Aug;61(8):1219-25. doi: 10.1136/gutjnl-2012-302339. Epub 2012 Jun 3. Gut. 2012. PMID: 22661495 Free PMC article. Review. No abstract available.

9

Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.

Bajaj JS, O'Leary JG, Reddy KR, Wong F, Olson JC, Subramanian RM, Brown G, Noble NA, Thacker LR, Kamath PS; NACSELD. Bajaj JS, et al. Among authors: wong f. Hepatology. 2012 Dec;56(6):2328-35. doi: 10.1002/hep.25947. Hepatology. 2012. PMID: 22806618 Free PMC article.

10

New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.

Wong F, O'Leary JG, Reddy KR, Patton H, Kamath PS, Fallon MB, Garcia-Tsao G, Subramanian RM, Malik R, Maliakkal B, Thacker LR, Bajaj JS; North American Consortium for Study of End-Stage Liver Disease. Wong F, et al. Gastroenterology. 2013 Dec;145(6):1280-8.e1. doi: 10.1053/j.gastro.2013.08.051. Epub 2013 Aug 30. Gastroenterology. 2013. PMID: 23999172 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,469 results

Search Page